Pharma

Doug Layman, Prescryptive President of Commercial Business, joins the ViVE podcast to share how Prescryptive’s Digital Prescription gives…

Congress is working on measures to bring down prescription drug costs. But Prescryptive CEO, Chris Blackley, says more…

New offering will engage, inform, and empower the healthcare consumer to drive product utilization, adherence, and real-time data…

Prescribers know it better than most: Medication nonadherence is a major challenge. An estimated 50% of patients don’t take…

The FTC’s investigation into the business practices of PBMs could expose the outsized influence PBMs have on access…

Prescryptive Health partnered with Eli Lilly and Company on a new subscription model to help lower costs for…

Prescryptive Health has partnered with Eli Lilly to create a subscription-based insulin program for employers that aims to…

The new financial model aims to provide price transparency while encouraging medication adherence.

Partnership will offer a comprehensive and transparent experience for Transcarent Members.

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

“With his name, brand and reputation, it has created a lot of interest and appropriately put a brighter…

Paige Clark, RPh, writes about the three steps all community pharmacists should take to be ready for security…